Viewing Study NCT02891161


Ignite Creation Date: 2025-12-24 @ 12:35 PM
Ignite Modification Date: 2026-02-01 @ 6:43 PM
Study NCT ID: NCT02891161
Status: TERMINATED
Last Update Posted: 2024-11-27
First Post: 2016-09-01
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Durvalumab And Radiation Therapy Followed by Adjuvant Durvalumab in Patients With Urothelial Cancer (T2-4 N0-2 M0) of the Bladder
Sponsor: Monika Joshi, MD
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Urothelial Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None durvalumab View
None MEDI4736 View
None anti-PD-L1 View